Baird’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$55.7M Buy
554,220
+27,776
+5% +$2.8M 0.57% 31
2014
Q4
$52.9M Buy
526,444
+96,008
+22% +$9.57M 0.56% 31
2014
Q3
$41.4M Buy
430,436
+81,321
+23% +$7.71M 0.58% 41
2014
Q2
$32.5M Buy
349,115
+309,673
+785% +$27.1M 0.46% 69
2014
Q1
$3.28M Buy
39,442
+20
+0.1% +$1.62K 0.05% 367
2013
Q4
$3.3M Buy
39,422
+275
+0.7% +$22.4K 0.06% 361
2013
Q3
$2.91M Buy
39,147
+474
+1% +$35.5K 0.05% 371
2013
Q2
$3.06M Buy
+38,673
New +$3.1M 0.06% 330

Other funds holding MJN

Baird's MJN Position: Q1 2015 in Review

Baird increased its Mead Johnson Nutrition Company (MJN) stake by 5.3% in Q1 2015, buying an estimated $2.8M and bringing the position to 554,220 shares worth $55.7M. The position accounts for 0.57% of the portfolio, ranked #31.

Baird first reported a position in MJN in Q2 2013 and has held it in 8 quarters since. 547 funds tracked by Wall St. Rank hold MJN as of Q1 2015.

  • Baird held 554,220 shares of Mead Johnson Nutrition Company worth $55.7M as of Q1 2015.
  • Baird bought 27,776 Mead Johnson Nutrition Company shares in Q1 2015, an estimated $2.8M.
  • Mead Johnson Nutrition Company made up 0.57% of Baird's portfolio in Q1 2015, its #31 holding.
  • Baird first reported a position in Mead Johnson Nutrition Company in Q2 2013 and has held it in 8 quarters since.
  • 547 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.